Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Charite University, Berlin, Germany
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
JSehouli, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01600573
First received: May 9, 2012
Last updated: March 14, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)